Richard A. Colvin - 04 Nov 2022 Form 4 Insider Report for bluebird bio, Inc. (BLUE)

Role
Chief Medical Officer
Signature
/s/ Katherine Breedis, Attorney-in-Fact
Issuer symbol
BLUE
Transactions as of
04 Nov 2022
Net transactions value
-$1,398
Form type
4
Filing time
08 Nov 2022, 16:46:30 UTC
Previous filing
03 Nov 2022
Next filing
13 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BLUE Common Stock Sale $1,398 -218 -0.29% $6.41 74,788 04 Nov 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares were sold to cover tax withholding obligations incurred in connection with the vesting of Restricted Stock Units.
F2 The range in prices for the transaction reported on this line was $6.24 to $6.46. The average weighted price was $6.4137. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.